Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 12/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 0.78 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.72 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | NPC1 | O15118 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.63 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29530821 | 0.86 | ADORA3 (1.00) | ADORA3MAPTRXFP1SMN1; SMN2MEN1 | |
| SCHEMBL4243345 | 0.84 | ADORA3 (1.00) | ADORA3MAPTRXFP1SMN1; SMN2MEN1 | |
| SCHEMBL18094502 | 0.83 | ADORA3 (0.71) | ADORA3MAPTSMN1; SMN2MEN1NPC1 | |
| SCHEMBL4241185 | 0.81 | ADORA3 (1.00) | ADORA3MAPTRXFP1SMN1; SMN2MEN1 | |
| SCHEMBL10248489 | 0.79 | ADORA3 (0.78) | ADORA3MAPTRXFP1SMN1; SMN2MEN1 | |
| SCHEMBL235277 | 0.79 | ADORA1 (0.78) | ADORA3MAPTRXFP1SMN1; SMN2MEN1 | |
| SCHEMBL2753298 | 0.79 | ADORA3 (1.00) | ADORA3MAPTRXFP1SMN1; SMN2MEN1 | |
| SCHEMBL9891812 | 0.78 | ADORA3 (0.74) | ADORA3MAPTRXFP1SMN1; SMN2MEN1 | |
| SCHEMBL6370742 | 0.78 | ADORA3 (0.71) | ADORA3MAPTRXFP1SMN1; SMN2MEN1 | |
| SCHEMBL16254958 | 0.78 | SMN1; SMN2 (1.00) | ADORA3MAPTRXFP1SMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4662319-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | Integrate Bioscience LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024168301-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | FUNCTION ONCOLOGY, INC. (US) | 2024-08-15 | — | — | WO | disclosed |
| WO-2003103675-A2 | COMBINATION TREATMENTS FOR PURINOCEPTOR-RELATED DISORDERS | ENDACEA, INC. (US) | 2003-12-18 | — | — | WO | disclosed |